Targeting the future in head and neck cancer. [electronic resource]
Producer: 20090325Description: 204-5 p. digitalISSN:- 1474-5488
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Carcinoma, Squamous Cell -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Head and Neck Neoplasms -- drug therapy
- Humans
- Quinazolines -- administration & dosage
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.